Home
About
Our Mission
Our Team
Platform
Pipeline
Pipeline
Newsroom
Latest News
Scientific Publications
Partnerships
Partnerships
Our Academic Collaborators
Contact Us

Seneca Therapeutics Therapeutics

Home
About
Our Mission
Our Team
Platform
Pipeline
Pipeline
Newsroom
Latest News
Scientific Publications
Partnerships
Partnerships
Our Academic Collaborators
Contact Us
Mason Duling
April 4, 2025

Seneca Valley Virus (SVV-001) Clinical Trial Opens at University of Miami

Mason Duling
April 4, 2025

A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

Clinical Trial Opens for Patients with High-Grade Neuroendocrine Cancer - InventUM

Older PostElevated expression of ANTXR1 gene in tumors is a poor prognostic biomarker for patients with bladder cancer

Subscribe

Sign up with your email address to receive news and updates.

Thank you!
Back to Top

© 2023 Seneca Therapeutics